Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01167608 · ClinicalTrials.gov registry record

Barriers to Mental Healthcare Utilization in Parkinson's Disease

A clinical trial, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
883
Enrollment target

NCT01167608: Completed study, sponsored by Rutgers, The State University of New Jersey.

NCT01167608 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 883 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01167608 has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
883 participants
Enrollment target

Study Summary

Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly. In most people, the illness is complicated by co-occurring psychiatric problems such as depression and anxiety. These non-motor concerns negatively affect the course and management of the disease, often leading to poor outcomes for both patients and their families. Despite these deleterious consequences, psychiatric symptoms in PD are both underreported by patients as well as under-recognized and under-treated by health care providers. The primary purpose of this study is to identify and describe barriers to mental healthcare utilization for people with Parkinson's disease. Secondary objectives include the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care. In order to accomplish these aims, participants will be asked to fill out an anonymous survey which will take about 15-30 minutes to complete. To best accommodate PD patients with varying levels of disability, participants will have the option to complete the survey online, on paper, or over the phone. The information obtained from this study will be used to support future treatment development efforts (i.e., phone and internet based interventions, community based trainings with local providers) intended to improve access and quality of mental health care for people with PD. To the best of the investigators knowledge, this is the first study to systematically examine barriers to mental healthcare utilization in PD in a national sample.

Primary Outcome

The purpose of this study was to assess the 3 most commonly reported past and future barriers to mental health services. This outcome represents the most common past barrier to mental health services reported by survey respondents. The outcome reported is the percentage of all respondents surveyed who endorsed this particular past barrier. This barrier can best be described as low mental health literacy.

Interventions

  • OTHER No Intervention. This is a cross-sectional survey study.

Trial Details

FieldValue
Enrollment Target 883 participants
Start Date 2010-06
Est. Completion 2013-03

What the finished NCT01167608 record still lists

NCT01167608 is an observational study that tracks outcomes without assigning an intervention. The registered 883 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which No Intervention. This is a cross-sectional survey study. is the first listed.

NCT01167608 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01167608 about?

NCT01167608 is a clinical study titled "Barriers to Mental Healthcare Utilization in Parkinson's Disease". Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly. In most people, the illness is complicated by co-occurring psychiatric problems such as depression and anxiety. These non-motor concerns negatively affect the course and management of the disease, often lea...

What is the current status of trial NCT01167608?

This trial is currently completed. The enrollment target is 883 participants. The study started on 2010-06. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01167608?

The interventions under investigation include: No Intervention. This is a cross-sectional survey study. (OTHER).

Who is sponsoring clinical trial NCT01167608?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07196748 · 882 participants · Phase 3

    A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT05174286 · 880 participants · NA

    Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

  • NCT05454280 · 880 participants · Phase 3

    Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

  • NCT05525663 · 880 participants · NA

    Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01167608, the US trial registry maintained by the National Library of Medicine. NCT01167608 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.